Grey Matters Health Inc. GREY

GREY Company Overview

Algernon Health Inc. is a clinical-stage biotechnology company focused on the development of novel therapies for unmet medical needs, primarily in the areas of neurological, psychiatric, and cardiometabolic diseases. The company operates within the biopharmaceutical and drug development industry and does not currently generate commercial product revenue, instead relying on equity financing and strategic transactions to fund research and development activities.

The company’s core strategy centers on repurposing and advancing known compounds through clinical trials to address conditions with limited effective treatments. Algernon Health Inc. was incorporated in Canada and has evolved from a diversified life sciences investment approach into a more focused clinical-stage drug development company, prioritizing internally developed programs and select subsidiaries to advance its pipeline.